Juisci, founded in 2021, is a promising player in the intersection of AI, Health Care, and Life Sciences. The company addresses the overwhelming influx of medical literature, which doubles every 73 days, through its cutting-edge technology that simplifies content discovery and processing. By utilizing AI to sift through content from thousands of sources across over 20 medical specialties, Juisci delivers reliable and digestible medical updates to professionals, enhancing their ability to stay informed with minimal time investment.
The innovative platform is not only beneficial for individual healthcare professionals but also serves healthcare organizations and life sciences companies aiming to boost their content output and engagement. Juisci's solution is strategically poised to enhance reach and deliver value-driven content at the organizational level.
The company has demonstrated significant traction, highlighted by a recent €4.00M grant investment secured in September 2025 from prominent investors like Ring Capital, Big Pi Ventures, Wendel Group, ⚡ SUPER CAPITAL ⚡, and Colloquium Brussels.
